Shell profits climb despite falling oil prices

Weather - Sydney 9°C

Shell profits climb despite falling oil prices

ECONOMY 05.02.2026

Shell profits climb despite falling oil prices / Photo: © AFP

British energy giant Shell said Thursday that its net profit rose 11 percent last year as higher volumes and lower costs helped to offset falling oil and gas prices.

Change text size:

Profit after tax climbed to $17.84 billion in 2025 from $16.1 billion a year earlier, Shell said in a statement.

Energy prices faced pressure last year on concerns that US President Donald Trump's tariffs would hurt economic growth. They dropped further as a result of higher output by OPEC+ nations.

More recently, prices have rallied as Trump ramped up military threats against major oil producer Iran, but have since cooled on easing tensions between Washington and Tehran.

Shell said its underlying earnings, which strip out some energy-price movements and one-off charges, dropped 22 percent to $18.53 billion last year.

In the fourth quarter alone, net profit fell 22 percent from the previous quarter, to $4.1 billion.

"In Q4, despite lower earnings... cash delivery remained solid," chief executive Wael Sawan said in the statement.

He added that Shell was raising its dividend to shareholders and would begin a new share buyback programme worth $3.5 billion.

Following the update, Shell's share price dropped 1.9 percent on London's top-tier FTSE 100 index, which was down 0.5 percent overall.

- 'Quarter to forget' -

"The final quarter was one which Shell will want to forget, although the numbers for the year as a whole were slightly more palatable," said Richard Hunter, head of markets at Interactive Investor.

"The volatility of the oil price inevitably had an effect as tepid demand and oversupply put a dampener on any price progress," he added.

The international oil price benchmark, Brent North Sea crude, was down 1.6 percent at $68.33 per barrel on Thursday.

Shell announced in November that it was ending its participation in two offshore wind projects in the North Sea, part of its shift away from alternative energy to focus on its fossil fuels business.

In an online video Thursday, Sawan said Shell had "entered 2026 as a more resilient organisation".

"We have raised the bar on operational performance, we are showing more discipline and making great progress to deliver more value with less emissions," he said.

Sawan added that Shell was focusing on "lower costs, further performance improvements supported by the transformative potential of AI, and a higher-returning portfolio".

The company, like some of its rivals, has scaled back various climate objectives in favour of more profitable oil and gas production.

Shell's British rival BP, which publishes its 2025 earnings next Tuesday, said last month that it would take a write-down of up to $5 billion linked to its own energy operations.

Shell's end of year was marked by survivors of a deadly 2021 typhoon in the Philippines filing a UK lawsuit against the company, seeking financial compensation for climate-related harms.

Typhoon Rai struck the southern and central regions of the Philippines in mid-December 2021, toppling power lines and trees and unleashing deadly floods that killed more than 400 people and left hundreds of thousands homeless.

The lawsuit, brought by the British law firm Hausfeld on behalf of 103 survivors, argues that Shell's carbon emissions contributed to climate change, impacting Philippine communities.

R.Evans--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size:

The National Times - Shell profits climb despite falling oil prices